[Potentialization by reserpine and rescinnamine of the cardiovascular and respiratory effects of veratrine].
D000959:Antihypertensive Agents; D002319:Cardiovascular System / Q000187:drug effects*; D006801:Humans; D012110:Reserpine / Q000494:pharmacology* / Q000031:analogs & derivatives; D012137:Respiratory System / Q000187:drug effects*; D046948:Secologanin Tryptamine Alkaloids / Q000494:pharmacology*; D014702:Veratrine; D014704:Veratrum Alkaloids / Q000494:pharmacology*
D000959:Antihypertensive Agents; D046948:Secologanin Tryptamine Alkaloids; D014704:Veratrum Alkaloids; D012110:Reserpine; D014702:Veratrine; C084826:rescinnamine
CARDIOVASCULAR SYSTEM/effect of drugs on; RAUWOLFIA ALKALOIDS/effects; RESERPINE/effects; RESPIRATORY TRACT/effect of drugs on; VERATRUM ALKALOIDS/effects
Potentialisation par la réserpine et la rescinnamine des effets cardiovasculaires et respiratoires de la vératrine.